The equity release market opens up
A more competitive market means retirees with equity release mortgages could save by switching provider.
A more competitive market means you could save by switching provider.
For cash-poor retirees who own their own home, equity-release plans have long offered a means to gain capital later in life. And with more people now taking out such plans, the market is increasingly competitive.As a result, if you took out an equity-release plan a few years ago, you may now be able to switch to a much better deal.
Equity-release plans enable older homeowners to unlock some of the value tied up in their properties while staying in the home. The money advanced is repaid, with interest, from the proceeds of the sale of the house when they die or move into long-term care. Traditionally, providers have charged expensive rates compared with standard mortgage deals.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Moreover, with interest accumulating over the lifetime of the loan, the final repayment cost can be very high. Most providers offer a no-negative-equity guarantee, so the sale of the property will always cover what is owed, but there may be little left over.
The lower the interest rate you pay, the less chance there is of that happening. The good news is that rates have come down as the market has grown: the number of products available went from 58 in 2016 to 139 in 2018, according to the Equity Release Council, a trade body. And while the average loan now costs 5.22% a year, down from 5.96%, the most competitive products cost less than 3.5%.
When it pays to switch
For those who took out equity-release plans at a time when rates were less competitive, the potential savings from switching are therefore compelling.
If you currently owe £100,000 and you are paying a pretty typical interest rate of 6% a year, the debt will have grown to around £182,000 in ten years' time; if you can move to a rate of, say, 3.5%, your debt in ten years' time would be only £142,000. Unfortunately, for most people, the calculation will not be quite so straightforward. Note that the Financial Conduct Authority, the City regulator, requires equity-release customers to take independent financial advice before signing up for any new product. This is likely to cost you between 1.5% and 2% of the transaction value. Finally, there is a very good chance your existing equity-release plan has early repayment charges, which you'll need to take into account.
Still, even assuming additional costs of £5,000 in the above example, covering the price of advice and exit fees, it would be less than three years before your switch paid off. It's worth thinking about.
If you’d like to find out how much equity you could release from your home, or to find out more about equity release in general, visit our partners, UK Experts Online, for a free report.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
David Prosser is a regular MoneyWeek columnist, writing on small business and entrepreneurship, as well as pensions and other forms of tax-efficient savings and investments. David has been a financial journalist for almost 30 years, specialising initially in personal finance, and then in broader business coverage. He has worked for national newspaper groups including The Financial Times, The Guardian and Observer, Express Newspapers and, most recently, The Independent, where he served for more than three years as business editor.
-
What the Employment Rights Bill means for your job
New workplace reforms are set to give employees new rights to benefits and flexible working
By Marc Shoffman Published
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published